199 related articles for article (PubMed ID: 9816043)
21. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.
Ahrendt SA; Chow JT; Yang SC; Wu L; Zhang MJ; Jen J; Sidransky D
Cancer Res; 2000 Jun; 60(12):3155-9. PubMed ID: 10866304
[TBL] [Abstract][Full Text] [Related]
22. Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data.
Lohmann D; Pütz B; Reich U; Böhm J; Präuer H; Höfler H
Am J Pathol; 1993 Mar; 142(3):907-15. PubMed ID: 8384408
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.
Gao W; Mady HH; Melhem MF; Keohavong P
Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763
[TBL] [Abstract][Full Text] [Related]
24. Gender differences in p53 mutational status in small cell lung cancer.
Tseng JE; Rodriguez M; Ro J; Liu D; Hong WK; Mao L
Cancer Res; 1999 Nov; 59(22):5666-70. PubMed ID: 10582680
[TBL] [Abstract][Full Text] [Related]
25. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
[TBL] [Abstract][Full Text] [Related]
27. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.
Tomizawa Y; Kohno T; Fujita T; Kiyama M; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Nakajima T; Yokota J
Oncogene; 1999 Jan; 18(4):1007-14. PubMed ID: 10023676
[TBL] [Abstract][Full Text] [Related]
28. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients.
Skaug V; Ryberg D; Kure EH; Arab MO; Stangeland L; Myking AO; Haugen A
Clin Cancer Res; 2000 Mar; 6(3):1031-7. PubMed ID: 10741731
[TBL] [Abstract][Full Text] [Related]
29. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
30. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
[TBL] [Abstract][Full Text] [Related]
31. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
32. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K
Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962
[TBL] [Abstract][Full Text] [Related]
33. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
34. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.
Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K
Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590
[TBL] [Abstract][Full Text] [Related]
35. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
36. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.
Ryberg D; Kure E; Lystad S; Skaug V; Stangeland L; Mercy I; Børresen AL; Haugen A
Cancer Res; 1994 Mar; 54(6):1551-5. PubMed ID: 8137262
[TBL] [Abstract][Full Text] [Related]
37. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
38. The TP53 gene, tobacco exposure, and lung cancer.
Toyooka S; Tsuda T; Gazdar AF
Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
[TBL] [Abstract][Full Text] [Related]
39. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA
Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438
[TBL] [Abstract][Full Text] [Related]
40. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]